Renal Cell Cancer Update
Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:46:22
- Mais informações
Informações:
Sinopse
Dr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York, discusses the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayBispecificNHL23)
